Clinical Development & Case Studies
Biomarkers are intended to replace the surrogate endpoints in clinical trials. Surrogate markers are used to conduct clinical trial and gather a good number of endpoints which is impractical when the primary end point is undesired or the event number is very small. The Biomarkers help in the diagnostics and the Biomarkers help in the clinical development processes. Biomarkers case study plays an important role in finding and using new treatments to the patients who are in need and new drugs can be used widely in various clinical practices.